Gajewski,T.F., Meng, Y., Blank, C., Brown, I., Kacha, A., Kline, J., and Harlin, H.: Immune resistance orchestrated by the tumor microenvironment. Immunol. Rev. 2006, 213:131–145.
Girardi, M., Oppenheim, D.E., Steele, C.R., Lewis, J.M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R.E., and Hayday, A.C.: Regulation of cutaneous malignancy by γδT cells. Science 2001, 294:605–609.
Kloor, M., Becker, C., Benner, A., Woerner, S.M., Gebert, J., Ferrone, S., and von Knebel Doeberitz, M: Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res. 2005, 65:6418–6424.
Koblish, H.K., Hansbury, M.J., Bowman, K.J., Yang, G., Neilan, C.L., Haley, P.J., Burn, T.C., Waeltz, P., Sparks, R.B., Yue, E.W., et al. : Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors. Mol. Cancer. Ther. 2010, 9:489–498.
Koebel, C.M., Vermi, W., Swann, J.B., Zerafa, N., Rodig, S.J., Old, L.J., Smyth, M.J., and Schreiber, R.D.: Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007, 450:903–907.
Koopman, L.A., Corver, W.E., van der Slik, A.R., Giphart, M.J., and Fleuren, G.J.: Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J. Exp. Med. 2000, 191:961–976.
Munn, D.H., and Mellor, A.L.: Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 2007, 117:1147–1154.
Ochsenbein, A.F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Hengartner, H., and Zinkernagel, R.M.: Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 2001, 411:1058–1064.
Peggs, K.S., Quezada, S.A., and Allison, J.P.: Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol. Rev. 2008, 224:141–165.
Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., and Bronte, V.: Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010, 22:238–244.
Schreiber, R.D., Old. L.J., and Smyth, M.J.: Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565–1570.